See more : Talkspace, Inc. (TALK) Income Statement Analysis – Financial Results
Complete financial analysis of Diagnostic Medical Systems S.A. (DGM.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Diagnostic Medical Systems S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- New Hope Corporation Limited (NHC.AX) Income Statement Analysis – Financial Results
- Ishihara Chemical Co., Ltd. (4462.T) Income Statement Analysis – Financial Results
- Lexston Life Sciences Corp. (LEXTF) Income Statement Analysis – Financial Results
- Fortune Rise Acquisition Corporation (FRLAU) Income Statement Analysis – Financial Results
- Birdman Inc. (7063.T) Income Statement Analysis – Financial Results
Diagnostic Medical Systems S.A. (DGM.PA)
About Diagnostic Medical Systems S.A.
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-arms, and posturology solutions. The company also exports its products. Diagnostic Medical Systems S.A. was founded in 1979 and is based in Mauguio, France.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 32.19M | 31.01M | 24.32M | 27.12M | 37.41M | 38.89M | 26.13M | 23.61M | 29.46M | 21.26M | 18.24M | 15.67M |
Cost of Revenue | 19.55M | 22.41M | 17.62M | 17.31M | 20.61M | 22.40M | 15.79M | 14.79M | 21.00M | 18.83M | 12.74M | 11.58M |
Gross Profit | 12.64M | 8.60M | 6.70M | 9.81M | 16.80M | 16.49M | 10.34M | 8.82M | 8.46M | 2.44M | 5.51M | 4.08M |
Gross Profit Ratio | 39.26% | 27.74% | 27.55% | 36.16% | 44.91% | 42.41% | 39.56% | 37.34% | 28.71% | 11.46% | 30.19% | 26.06% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.47M | 5.29M | 5.20M | 5.78M | 8.61M | 7.28M | 4.94M | 3.84M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.17M | 3.67M |
SG&A | 5.47M | 5.29M | 5.20M | 5.78M | 8.61M | 7.28M | 4.94M | 3.84M | 0.00 | 0.00 | 4.17M | 3.67M |
Other Expenses | 10.74M | 7.76M | 6.70M | 7.67M | 9.79M | 12.08M | 6.32M | 5.28M | 8.95M | 3.39M | 6.86M | 6.68M |
Operating Expenses | 16.21M | 13.04M | 11.90M | 13.44M | 18.40M | 19.36M | 11.26M | 9.13M | 8.95M | 3.39M | 11.03M | 10.35M |
Cost & Expenses | 35.76M | 35.45M | 29.52M | 30.75M | 39.01M | 41.75M | 27.05M | 23.92M | 29.96M | 22.22M | 23.77M | 21.93M |
Interest Income | 4.00K | 20.00K | 1.00K | 21.00K | 50.00K | 7.00K | 0.00 | 0.00 | 0.00 | 38.00K | 59.00K | 127.00K |
Interest Expense | 893.00K | 202.00K | 132.00K | 113.00K | 334.00K | 53.00K | 0.00 | 0.00 | 0.00 | 137.00K | 219.00K | 140.00K |
Depreciation & Amortization | 3.13M | 1.26M | 1.63M | 1.33M | 516.00K | 2.46M | 934.00K | 852.00K | 786.00K | 842.00K | 776.00K | 1.34M |
EBITDA | -1.22M | -1.65M | -3.64M | -1.10M | -136.00K | 1.08M | -148.00K | -119.00K | 320.00K | -745.00K | -4.69M | -4.79M |
EBITDA Ratio | -3.78% | -5.31% | -14.95% | -4.06% | -0.36% | 2.77% | -0.57% | -0.50% | 1.09% | -3.50% | -25.71% | -30.58% |
Operating Income | -4.35M | -2.90M | -5.27M | -2.43M | -652.00K | -1.38M | -1.08M | -971.00K | -466.00K | -1.59M | -5.47M | -6.14M |
Operating Income Ratio | -13.51% | -9.36% | -21.65% | -8.97% | -1.74% | -3.55% | -4.14% | -4.11% | -1.58% | -7.46% | -29.97% | -39.16% |
Total Other Income/Expenses | -1.19M | -335.00K | -186.00K | 317.00K | -664.00K | -1.27M | 13.00K | -16.00K | -1.00K | -137.00K | -219.00K | -140.00K |
Income Before Tax | -5.54M | -3.24M | -5.45M | -2.11M | -1.32M | -2.65M | -1.07M | -987.00K | -467.00K | -1.72M | -5.69M | -6.28M |
Income Before Tax Ratio | -17.19% | -10.44% | -22.42% | -7.80% | -3.52% | -6.80% | -4.09% | -4.18% | -1.59% | -8.11% | -31.17% | -40.05% |
Income Tax Expense | -1.00K | 202.00K | 1.00K | 113.00K | 30.00K | 33.00K | 27.00K | -16.00K | -1.00K | 618.00K | 219.00K | -205.00K |
Net Income | -5.53M | -3.44M | -5.45M | -2.23M | -1.35M | -2.68M | -1.10M | -971.00K | -466.00K | -2.34M | -5.91M | -6.07M |
Net Income Ratio | -17.19% | -11.09% | -22.42% | -8.21% | -3.60% | -6.89% | -4.19% | -4.11% | -1.58% | -11.01% | -32.37% | -38.75% |
EPS | -0.34 | -0.21 | -0.34 | -0.14 | -0.09 | -0.19 | -0.14 | -0.12 | -0.11 | -0.55 | -1.93 | -2.24 |
EPS Diluted | -0.34 | -0.21 | -0.34 | -0.14 | -0.07 | -0.14 | -0.14 | -0.11 | -0.09 | -0.46 | -1.62 | -2.24 |
Weighted Avg Shares Out | 16.12M | 16.12M | 16.12M | 15.86M | 15.47M | 13.97M | 7.85M | 8.05M | 4.22M | 4.22M | 3.06M | 2.71M |
Weighted Avg Shares Out (Dil) | 16.12M | 16.12M | 16.12M | 15.86M | 19.81M | 18.60M | 7.98M | 8.54M | 5.06M | 5.06M | 3.64M | 2.71M |
Source: https://incomestatements.info
Category: Stock Reports